CIRCULATING TUMOR CELLS (CTC) AND ARTIFICIAL NEURAL NETWORK (ANN) IN METASTATIC BREAST CANCER (MBC) PATIENTS

被引：0
|
作者：
Giordano, A. [1 ]
Giuliano, M. [1 ]
De Laurentiis, M. [2 ]
Eleuteri, A. [3 ]
Iorio, F. [4 ]
Tagliaferri, R. [5 ]
Reuben, J. [6 ]
Hortobagyi, G. N. [1 ]
de Placido, S. [7 ]
Cristofanilli, M. [8 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Naples Federico 2, Dept Endocrinol & Mol Oncol, Naples, Italy
[3] Royal Liverpool Univ Hosp, Med Phys & Clin Engn, Liverpool, Merseyside, England
[4] TeleThon Inst Genet & Med, Syst Synthet & Computat Lab, Naples, Italy
[5] Univ Salerno, Neurone Lab, Fisciano, Italy
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Univ Naples Federico 2, Naples, Italy
[8] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25O
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [41] Gene expression profiles of circulating tumor cells (CTCs) in patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AI)
    Reijm, E. A.
    Sieuwerts, A. M.
    Bolt-de Vries, J.
    Onstenk, W.
    Dirix, L. Y.
    Hamberg, A. P.
    Kraan, J.
    Martens, J. W. M.
    Berns, P. M. J. J.
    Sleijfer, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S154 - S154
  • [42] Circulating tumor cell (CTC) and CA2729 as predictors of outcome in patients with metastatic breast cancer (MBC) in the prospective TBCRC 005 biomarker study.
    Bardia, A.
    Huang, P.
    Zhang, Z.
    Sokoll, L.
    Ingle, J. N.
    Carey, L. A.
    Lin, N. U.
    Nanda, R.
    Viswanathan, K.
    Wolff, A. C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] mRNA expression profiles in circulating tumor cells (CTCs) of patients with metastatic breast cancer (MBC) treated with aromatase inhibitors (AI)
    Reijm, Esther Anneke
    Sieuwerts, Anieta M.
    Bolt-de Vries, Joan
    Mostert, Bianca
    Onstenk, Wendy
    Peeters, Dieter
    Dirix, Luc Yves
    Seynaeve, Caroline
    Jager, A.
    de Jongh, Felix E.
    Hamberg, Paul
    van Galen, Anne M.
    Kraan, Jaco
    Jansen, Maurice P. H. M.
    Gratama, Jan-Willem
    Foekens, John A.
    Martens, John W. M.
    Berns, Els M. J. J.
    Sleijfer, Stefan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Prognostic Value of Circulating Tumor Cells (CTC) in HER-2 Positive Metastatic Breast Cancer (MBC) Patients (pts) Treated with Anti-HER2-Based Therapy
    Giuliano, M.
    Giordano, A.
    Handy, B. C.
    Ueno, N. T.
    Alvarez, R. H.
    Hortobagyi, G. N.
    Reuben, J. M.
    Valero, V.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2010, 70
  • [45] Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC)
    Magbanua, M. J. M.
    Sosa, E.
    Roy, R.
    Eisenbud, L.
    Scott, J.
    Olshen, A.
    Pinkel, D.
    Rugo, H. S.
    Park, J. W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [46] BONE MARROW (BM) INVOLVEMENT IS ASSOCIATED WITH HIGHER NUMBERS OF CIRCULATING TUMOR CELLS (CTCS) IN METASTATIC BREAST CANCER (MBC) PATIENTS
    Grisanti, S.
    Almici, C.
    Consoli, F.
    Montani, E.
    Amoroso, V.
    Pedersini, R.
    Vassalli, L.
    Morassi, L.
    Lucini, L.
    Simoncini, E. L.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 42 - 42
  • [47] Monitoring circulating tumor cell (CTC) levels to predict rapid progression in metastatic breast cancer (MBC): A prospective, multi-institutional trial
    Hayes, DF
    Cristofanilli, M
    Budd, GT
    Ellis, M
    Stopeck, A
    Matera, J
    Miller, MC
    Doyle, GV
    Allard, WJ
    Terstappen, LW
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 5S - 5S
  • [48] Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer
    Mego, M.
    Gao, H.
    Cohen, E. N.
    Anfossi, S.
    Giordano, A.
    Sanda, T.
    Fouad, T. M.
    De Giorgi, U.
    Giuliano, M.
    Woodward, W. A.
    Alvarez, R. H.
    Valero, V.
    Ueno, N. T.
    Hortobagyi, G. N.
    Cristofanilli, M.
    Reuben, J. M.
    [J]. JOURNAL OF CANCER, 2016, 7 (09): : 1095 - 1104
  • [49] Circulating tumor DNA (ctDNA) as a molecular monitoring tool in metastatic breast cancer (MBC)
    Austin, Laura Katherine
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Predictive and prognostic value of circulating tumor DNA (ctDNA) compared to circulating tumor cells (CTC) in a prospective cohort of metastatic breast cancer patients: The UCBG COMET trial
    Pierga, Jean-Yves
    Silveira, Amanda
    Girard, Elodie
    Lorgis, Veronique
    Tanguy, Marie-Laure
    Albaud, Benoit
    Tredan, Olivier
    Dubot, Coraline
    Hego, Caroline
    Jacot, William
    Goncalves, Anthony
    Debled, Marc
    Levy, Christelle
    Ferrero, Jean-Marc
    Jouannaud, Christelle
    Mouret-Reynier, Marie-Ange
    Dalenc, Florence
    Baulande, Sylvain
    Lemonnier, Jerome
    Berger, Frederique
    Bidard, Francois-Clement
    Proudhon, Charlotte
    [J]. CANCER RESEARCH, 2020, 80 (16)
12345